EUVIMEDEUVIMED entdecken
EvaluationsstudieVergleichsstudieOpen Access · CC BY 4.0

Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria

J O Olabamiji iD, K Ochei iD, O Daniel, R Eneogu iD, A Ihesie iD, D Nongo iD, A Agbaje iD, P Dakum iD, E Elom iD, A Mwansasu, C Colvin iD, N Diaz und 7 weitere

Journal of Clinical Microbiology · 2026

DOI: 10.1128/jcm.01041-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2026. Verfasst von J O Olabamiji und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Virology Nigeria, International Research Centre of Excellence (IRCE), BAZE University, Abuja, Nigeria. Hauptthemen laut MEDLINE: Feces, Tuberculosis, Molecular Diagnostic Techniques, Mycobacterium tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Agency for International Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization (WHO) recommends testing stool with Xpert MTB/RIF Ultra (Xpert-Ultra) as an initial diagnostic test for detection of tuberculosis (TB) and rifampicin resistance in children. The option of testing stool on the Truenat platform could benefit children and their caregivers in remote areas where GeneXpert is not available. We report the results of research to validate a protocol for processing and testing stool on Truenat using an adapted Simple One Step (SOS) stool method in routine settings in Nigeria. Stool specimens from children with presumptive TB were tested with Truenat MTB Plus (Truenat) and Xpert-Ultra using a comparative cross-sectional study design. A total of 510 children were enrolled and submitted a stool specimen. Of these, 482 (94.5%) had valid results on both platforms, 28 (5.8%) with MTB detected and 454 MTB not detected. Of the 28 with MTB detected, eight were detected on both platforms, seven on Truenat only, and 13 on Xpert-Ultra only. The concordance rate between Truenat and Xpert-Ultra was high at 95.8%. Significantly more non-determinate (error/invalid) results were observed with Truenat compared to Xpert-Ultra (4.7% versus 1.2% respectively; P < 0.001). Truenat can accurately detect MTB using 100 mg of stool with an adapted SOS stool protocol. Further optimizing extraction methods could reduce the frequency of non-determinate results. These results hold promise for expansion of childhood TB diagnosis services to hard-to-reach areas with limited infrastructure that are suitable for Truenat placement. Global scale-up of these alternative testing approaches will be necessary to close the gap in childhood TB case finding. IMPORTANCE Following WHO recommendations, high TB burden countries have commenced testing stool on GeneXpert to improve TB case finding among children and others who may not easily produce sputum. In previous work, we adapted the Simple One Step (SOS) stool method for GeneXpert for the Truenat platform. In the present study, we validated the revised processing method under routine conditions in health care facilities in Nigeria. We tested stool from 510 children with presumptive TB on both the GeneXpert and Truenat platforms across a variety of health care settings. Concordance between Truenat and Xpert MTB detection was high at 95.8%, confirming stool can be tested on Truenat in routine services. Our study demonstrates that TB diagnostic testing for children can be provided in peripheral health facilities located in remote geographic areas with limited infrastructure where Truenat can be placed. Global scale-up will help further close the gap in childhood TB case finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesTuberculosisMolecular Diagnostic TechniquesMycobacterium tuberculosisHumansNigeriaCross-Sectional StudiesChild, PreschoolChildFemaleMaleInfantSensitivity and SpecificityAdolescent

Stichwörter der Autor:innen

TruenatXpert MTB/RIF Ultrachildhood TBchildrenhard-to-reachstooltuberculosis

Autor:innen und Institutionen

  • Institute of Human Virology Nigeria, International Research Centre of Excellence (IRCE), BAZE University, Abuja, Nigeria.
  • USAID Nigeria, Abuja, Nigeria.
  • National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
  • IDDS project, Washington, DC, USA.
  • Office of Infectious Disease, TB Division, Credence Management Solutions, LLC. Support contractor to USAID Bureau for Global Health, Washington, DC, USA.
  • Office of Sustainable Development, Health Division, Public Health Institute, Support contractor to USAID Bureau for Africa, Washington, DC, USA.

ORCID-Profile: J O Olabamiji, K Ochei, R Eneogu, A Ihesie, D Nongo, A Agbaje, P Dakum, E Elom, C Colvin, P de Haas, E Klinkenberg

Förderung

  • United States Agency for International Development

Zitieren

APA

Olabamiji, J. O., Ochei, K., Daniel, O., Eneogu, R., Ihesie, A., Nongo, D., Agbaje, A., Dakum, P., Elom, E., Mwansasu, A., Colvin, C., Diaz, N., Adelekan, A., Oyelaran, S., Mensah, C., Odola, O., Olayemi, A., de Haas, P., & Klinkenberg, E. (2026). Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01041-25

Vancouver

Olabamiji JO, Ochei K, Daniel O, Eneogu R, Ihesie A, Nongo D, et al. Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria. Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.01041-25

BibTeX
@article{Olabamiji2026,
  author = {Olabamiji, J O and Ochei, K and Daniel, O and Eneogu, R and Ihesie, A and Nongo, D and Agbaje, A and Dakum, P and Elom, E and Mwansasu, A and Colvin, C and Diaz, N and Adelekan, A and Oyelaran, S and Mensah, C and Odola, O and Olayemi, A and de Haas, P and Klinkenberg, E},
  title = {Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  doi = {10.1128/jcm.01041-25}
}
Kostenlos starten →